STOCK TITAN

CBD Life Sciences Inc. (CBDL) Nears Final Lease Agreement for Second High-Traffic Retail Location in Premier Arizona Mall, Signaling Major Expansion Phase

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags

CBD Life Sciences (OTC:CBDL) is finalizing a lease agreement for its second retail location in Arizona's Chandler Fashion Center, marking a significant expansion of its physical presence. The strategic move positions CBDL in a high-traffic mall environment operated by a major management company overseeing 20+ retail properties nationwide.

The new store will showcase CBDL's premium product lines, including their 8000mg Nano CBD Pain Cream, Delta-8 Gummies, Mushroom Gummies, and CBD Coffee Creamers. The location will offer in-store sampling, education, and wellness consultations.

This expansion aligns with projections for the U.S. CBD market to reach $36 billion by 2032, growing at a 21.7% CAGR. The strategic location in a premier mall positions CBDL to capture significant foot traffic and potentially expand to other locations through the mall operator's nationwide network.

CBD Life Sciences (OTC:CBDL) sta finalizzando un contratto di locazione per il suo secondo punto vendita in Arizona, presso il Chandler Fashion Center, segnando un'importante espansione della sua presenza fisica. Questa mossa strategica posiziona CBDL in un centro commerciale ad alto traffico gestito da una grande società che amministra oltre 20 proprietà commerciali a livello nazionale.

Il nuovo negozio presenterà le linee di prodotti premium di CBDL, tra cui la crema antidolorifica Nano CBD da 8000mg, le caramelle gommose Delta-8, le caramelle ai funghi e le creme al caffè con CBD. La sede offrirà campionature in negozio, sessioni informative e consulenze sul benessere.

Questa espansione è in linea con le proiezioni del mercato CBD statunitense, che raggiungerà i 36 miliardi di dollari entro il 2032, con una crescita annuale composta del 21,7%. La posizione strategica in un centro commerciale di primo livello consente a CBDL di attrarre un significativo flusso di visitatori e di potenzialmente espandersi in altre sedi attraverso la rete nazionale dell'operatore del centro commerciale.

CBD Life Sciences (OTC:CBDL) está finalizando un contrato de arrendamiento para su segunda tienda minorista en Arizona, en el Chandler Fashion Center, marcando una expansión significativa de su presencia física. Este movimiento estratégico posiciona a CBDL en un centro comercial de alto tráfico operado por una importante empresa que gestiona más de 20 propiedades comerciales a nivel nacional.

La nueva tienda exhibirá las líneas premium de productos de CBDL, incluyendo su crema para el dolor Nano CBD de 8000mg, gomitas Delta-8, gomitas de hongos y cremas de café con CBD. La ubicación ofrecerá muestras en tienda, educación y consultas de bienestar.

Esta expansión está alineada con las proyecciones del mercado de CBD en EE.UU., que alcanzará los 36 mil millones de dólares para 2032, con una tasa de crecimiento anual compuesta del 21.7%. La ubicación estratégica en un centro comercial de primer nivel posiciona a CBDL para captar un tráfico peatonal significativo y potencialmente expandirse a otras ubicaciones mediante la red nacional del operador del centro comercial.

CBD Life Sciences (OTC:CBDL)는 애리조나 주 챈들러 패션 센터에 두 번째 소매점을 위한 임대 계약을 마무리하고 있어 물리적 입지를 크게 확장하고 있습니다. 이 전략적 조치는 전국에 20개 이상의 소매 시설을 운영하는 주요 관리 회사가 운영하는 유동 인구가 많은 쇼핑몰 환경에 CBDL을 위치시킵니다.

새 매장에서는 8000mg 나노 CBD 통증 크림, 델타-8 구미, 버섯 구미, CBD 커피 크리머 등 CBDL의 프리미엄 제품 라인을 선보일 예정입니다. 매장 내 샘플링, 교육, 웰니스 상담도 제공됩니다.

이번 확장은 미국 CBD 시장이 2032년까지 360억 달러에 이를 것이라는 전망과 맞물려 있으며, 연평균 성장률 21.7%을 기록할 것으로 예상됩니다. 주요 쇼핑몰 내 전략적 위치는 CBDL이 상당한 유동 인구를 확보하고 쇼핑몰 운영자의 전국 네트워크를 통해 다른 지점으로 확장할 가능성을 높입니다.

CBD Life Sciences (OTC:CBDL) est en train de finaliser un contrat de location pour son deuxième point de vente en Arizona, au Chandler Fashion Center, marquant une expansion significative de sa présence physique. Cette décision stratégique positionne CBDL dans un centre commercial à fort trafic, géré par une grande société de gestion supervisant plus de 20 propriétés commerciales à l'échelle nationale.

Le nouveau magasin présentera les gammes de produits premium de CBDL, incluant leur crème anti-douleur Nano CBD 8000mg, les gummies Delta-8, les gummies aux champignons et les crèmes pour café au CBD. Le site proposera des dégustations en magasin, des sessions éducatives et des consultations bien-être.

Cette expansion s’aligne sur les projections du marché américain du CBD, qui devrait atteindre 36 milliards de dollars d’ici 2032, avec un taux de croissance annuel composé de 21,7%. L’emplacement stratégique dans un centre commercial de premier plan permet à CBDL de capter un flux important de visiteurs et potentiellement de s’étendre à d’autres emplacements via le réseau national de l’exploitant du centre commercial.

CBD Life Sciences (OTC:CBDL) steht kurz vor dem Abschluss eines Mietvertrags für seinen zweiten Einzelhandelsstandort im Chandler Fashion Center in Arizona, was eine bedeutende Erweiterung der physischen Präsenz markiert. Dieser strategische Schritt positioniert CBDL in einem stark frequentierten Einkaufszentrum, das von einer großen Managementgesellschaft betrieben wird, die landesweit über 20 Einzelhandelsimmobilien verwaltet.

Der neue Laden wird die Premium-Produktlinien von CBDL präsentieren, darunter die 8000mg Nano CBD Schmerzcreme, Delta-8 Gummibärchen, Pilz-Gummis und CBD-Kaffeesahne. Der Standort wird In-Store-Proben, Schulungen und Wellness-Beratung anbieten.

Diese Expansion steht im Einklang mit den Prognosen, dass der US-CBD-Markt bis 2032 36 Milliarden US-Dollar erreichen wird, mit einer jährlichen Wachstumsrate (CAGR) von 21,7%. Die strategische Lage in einem erstklassigen Einkaufszentrum positioniert CBDL, um erheblichen Kundenverkehr zu gewinnen und sich möglicherweise über das landesweite Netzwerk des Einkaufszentrumsbetreibers auf weitere Standorte auszudehnen.

Positive
  • Strategic location in high-traffic Chandler Fashion Center mall with millions of annual visitors
  • Partnership with major mall operator managing 20+ properties enables potential nationwide expansion
  • Projected CBD market growth to $36 billion by 2032 with 21.7% CAGR supports expansion timing
  • Full-scale showcase of premium product lines with in-store sampling and education capabilities
Negative
  • Lease agreement not yet finalized, introducing execution risk
  • Significant investment required for retail buildout and inventory
  • Operating costs will increase with physical retail presence

U.S. CBD market projected to exceed $36 billion by 2032 as foot traffic rebounds in top-tier malls with over 122 million monthly U.S. shoppers - CBDL strategically positioned at the intersection of both trends

SCOTTSDALE, ARIZONA / ACCESS Newswire / July 29, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), an emerging leader in the cannabinoid and alternative wellness space, is excited to announce that the company is in the final stages of executing a lease agreement for its second brick-and-mortar retail location, marking a major milestone in its aggressive growth strategy. The new store will be housed inside one of Arizona's most prominent high-traffic malls, reflecting the company's continued upward trajectory and expansion into mainstream consumer markets.

This development signals more than just a new storefront-it represents a gateway to exponential exposure, foot traffic, and revenue growth for the company. By positioning itself within a top-tier shopping destination that welcomes millions of visitors annually, CBDL is not only elevating its brand visibility but is also tapping into a high-conversion retail environment where health-conscious, trend-forward consumers converge daily.

While the specific location is being finalized, management has confirmed that the site is in Chandler Fashion Center, a premier regional mall recognized for its retail volume, luxury anchors, and central location within a rapidly expanding metro. The mall is operated by a management company that oversees a portfolio of over 20 major malls and retail properties across the U.S.-opening the door for potential multi-state expansion, cross-location partnerships, and accelerated national exposure.

"This is a transformative moment for CBDL," said a spokesperson for the company. "We're not just opening another store-we're planting a flag in one of the busiest, most commercially vibrant locations in the Southwest. This is the kind of move that can put our brand in front of thousands of new potential customers daily and substantially boost both revenue and long-term brand equity."

This new location will serve as a full-scale showcase of CBD Life Sciences' fastest-growing and most in-demand product lines, including the ultra-potent 8000mg Nano CBD Pain Cream, its newly released Delta-8 Gummies, adaptogenic Mushroom Gummies infused with lion's mane, reishi, and ashwagandha, as well as its fan-favorite Mellow Mornings CBD Coffee Creamers. The store will deliver a premium retail experience, complete with in-store sampling, customer education, and wellness consultations-bridging the gap between natural health innovation and high-end retail.

The physical presence at this level not only solidifies CBDL's consumer credibility but also supports its wholesale and B2B strategy. With the CBD market forecasted to reach $36 billion by 2032, growing at a CAGR of 21.7%, CBDL's expansion into physical retail reflects strategic timing that aligns with both investor confidence and rising consumer demand. The new storefront is expected to deliver robust ROI through in-store sales, cross-selling opportunities, and increased direct-to-consumer education that online retail alone cannot achieve.

Moreover, the relationships being developed through this expansion could be instrumental in unlocking a national footprint. The mall's parent management group holds significant influence in the commercial real estate space, and CBDL's entry could be the first of many retail opportunities in key markets across the country.

"This isn't just about one new store-it's about building a long-term pipeline," the spokesperson added. "Every square foot of this new location represents our commitment to growth, profitability, and delivering shareholder value. We've worked hard to position ourselves as not only a product innovator but a retail contender in the wellness space."

CBD Life Sciences Inc. plans to provide ongoing updates to shareholders as the lease is finalized and buildout begins. The company has already started preliminary planning to ensure a fast and impactful rollout once the deal is complete.

With a second location nearly secured, a growing line of category-leading products, and multiple new wholesale distribution deals on the horizon, CBDL is entering its most dynamic growth phase to date.

About CBD Life Sciences Inc. (CBDL)

CBD Life Sciences Inc. is an innovative health and wellness company committed to the research, development, and distribution of premium cannabidiol (CBD) products through its core brand, CBD Vault. From topicals and tinctures to wellness beverages and skincare solutions, CBDL is building a portfolio of products designed for maximum efficacy, transparency, and consumer trust.

Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: cbdvaultaz@gmail.com

Stay Connected & Be the First to Try Our New Functional Mushroom Products!

Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop

Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.

Contact Information
Lisa Nelson
CEO
cbdvaultaz@gmail.com
4802091720

SOURCE: CBD Life Sciences, Inc.



View the original press release on ACCESS Newswire

FAQ

What is CBD Life Sciences (CBDL) new retail expansion plan for 2025?

CBDL is finalizing a lease agreement for its second retail location in Chandler Fashion Center, a premier Arizona mall, to showcase its CBD product lines with in-store sampling and wellness consultations.

Where will CBDL's new retail store be located?

The new store will be located in Chandler Fashion Center, a premier regional mall in Arizona operated by a management company that oversees more than 20 major malls across the U.S.

What products will CBDL offer at its new retail location?

The store will feature CBDL's premium products including 8000mg Nano CBD Pain Cream, Delta-8 Gummies, Mushroom Gummies with lion's mane, reishi, and ashwagandha, and CBD Coffee Creamers.

What is the projected size of the U.S. CBD market by 2032?

The U.S. CBD market is projected to exceed $36 billion by 2032, growing at a CAGR of 21.7%.

How does this expansion affect CBDL's growth strategy?

This expansion provides CBDL access to high foot traffic, enables direct consumer education, and creates potential for nationwide expansion through the mall operator's network of 20+ properties.
Cbd Life Science

OTC:CBDL

CBDL Rankings

CBDL Latest News

CBDL Stock Data

1.10M
141.69M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Scottsdale